Sponsor Pipeline

Staidson (Beijing) Biopharmaceuticals Co., Ltd Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
4
Active Trials
4
Recruiting
2
Phase 3
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-07-29 NCT07168161
BDB-001 Phase III Trial in ANCA-Associated Vasculitis		 Trial sites expanded: 60 -> 65 locations
Active Trials by Phase
Phase 3
2
Phase 2
1
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07208591 To Evaluate The Safety and Efficacy of STSA-1002 Injection in Patients With Acute… Acute Respiratory Distress Syndrome (ARDS) Recruiting
NCT07168161 BDB-001 Phase III Trial in ANCA-Associated Vasculitis ANCA Associated Vasculitis (AAV) Recruiting
Phase 2
NCT06975748 A Phase II Study of STSP-0902 Ophthalmic Solution in Patients With Neurotrophic Keratitis Neurotrophic Keratitis Recruiting
Phase 1
NCT06948799 A Study to Evaluate the Safety and Tolerability of Single and Multiple Dose of STSP-0902… Oligozoospermia Recruiting
Get alerts when Staidson (Beijing) Biopharmaceuticals Co., Ltd's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free